HZNP Stock Recent News
HZNP LATEST HEADLINES
If you need an "end-of-the-year stock, here are three reasons why Horizon Therapeutics could be an outstanding stock to consider.
Cramer explained how three corporate deals announced on Monday helped push stocks up.
Yahoo Finance anchors Seana Smith and Jared Blikre discuss Amgen set to acquire Horizon Therapeutics for more than $26 billion as the company dives deeper into rare disease treatment.
Amgen Inc. said Monday that it's acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
Horizon is the largest disclosed holding of John Paulson's family office Paulson & Co., according to Forbes.
Amgen is acquiring Horizon Therapeutics for $27.8 billion. The deal immediately adds $3.7 billion in annual revenue.
Yahoo Finance's Anjalee Khemlani explains news of a major biotech merger as Amgen is set to acquire Horizon Therapeutics.
Amgen Inc. will acquire Horizon Therapeutics Public Limited Company for $116.50 per share in an all-cash transaction. This is a suboptimal exit for Horizon shareholders, but we should acknowledge the difficult market conditions.
Consensus is currently for a 50 basis point (bps) hike mid-week, which will bring the Fed funds rate over +4% for the first time in 15 years.
Wall Street Awaits Key Fed FOMC Decision